Intelligent Bio Solutions completes interference study for fingerprint codeine screening system ahead of FDA filing

Reuters2026/08/03 12:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Intelligent Bio Solutions completed a clinical interference study supporting its FDA 510(k) filing for U.S. clearance to detect codeine.
Results have not been presented; data analysis is underway with independent verification planned using LC-MS/MS.
Study indicates common external contaminants on fingertips did not compromise system performance in field-like conditions.
Work feeds a broader evidence package; the 510(k) submission remains targeted for calendar H2 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608030830PRIMZONEFULLFEED9802308) on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Intelligent Bio Solutions completes interference study for fingerprint codeine screening system ahead of FDA filing

You may also like

Crypto prices